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Abstract
Background: Rare diseases may elude diagnosis due to unfamiliarity of the treating physicians with the specific
disorder. Yet, advances in genetics have tremendously enhanced our ability to establish specific and sometimes
surprising diagnoses.
Case presentation: We report a case of renal Fanconi syndrome associated with intermittent hypoglycemic
episodes, the specific cause for which remained elusive for over 30 years, despite numerous investigations,
including three kidney and one liver biopsy. The most recent kidney biopsy showed dysmorphic mitochondria,
suggesting a mitochondrial disorder. When her son presented with hypoglycemia in the neonatal period, he
underwent routine genetic testing for hyperinsulinemic hypoglycemia, which revealed a specific mutation in HNF4A.
Subsequent testing of the mother confirmed the diagnosis also in her.
Conclusion: Modern sequencing technologies that test multiple genes simultaneously enable specific diagnoses, even
if the underlying disorder was not clinically suspected. The finding of mitochondrial dysmorphology provides a potential
clue for the mechanism, by which the identified mutation causes renal Fanconi syndrome.
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Background
There is a very large number of rare diseases, which
most clinicians will never encounter in their lifetime,
posing a challenge to the establishment of a correct
diagnosis. As of November 1st 2016, there were 8270
different phenotypic descriptions of diseases listed in the
Online Mendelian Inheritance in Man database (OMIM,
http://www.omim.org). Since the completion of the
Human Genome Project in 2003, our understanding of
the genetic cause of these disease has improved dramati-
cally and with it our ability to make precise diagnoses
[1]. Currently, just over half (4865) of the phenotypes
listed in OMIM have an identified molecular basis and
that number is increasing rapidly. This brings about a
shift in the practice of medicine such that the diagnosis
of rare diseases is more and more established by
comprehensive genetic testing, rather than targeted in-
vestigations. Renal Fanconi syndrome (RFS) refers to a
generalized dysfunction of the proximal tubule, leading
to wasting of filtered solutes in the urine [2]. Clinical
consequences include rickets and failure-to-thrive in
children and osteomalacia in adults. RFS is very rare and
can be acquired or inherited, with further subdivision of
the latter based on the underlying genetics [3]. Here we
describe a patient who went undiagnosed for more than
30 years despite numerous investigations. Her son pre-
sented with the same disorder in the neonatal period
and routine genetic testing identified the specific cause,
enabling the correct diagnosis also in the mother. Inves-
tigations previously carried out in the mother provide
some clues to the underlying pathophysiology of the
disorder.
Case presentation
In March 1984, a 3-year old girl was admitted to Great
Ormond Street Hospital (GOSH) for suspected RFS. She
had been born at 35-weeks gestation and spent the first
2 weeks of life in hospital because of jaundice and
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recurrent hypoglycaemia. Investigations at the time in-
cluded urine amino acid concentrations, which were
considered consistent with a diagnosis of Hartnup dis-
ease, an autosomal dominant disorder caused by defect-
ive neutral amino acid re-uptake in the proximal tubule
and which can be associated with a skin rash and neuro-
logical problems [4]. Over the next 2 years, she was
noted to have delayed gross motor milestones, especially
walking, thought to be secondary to the disorder and
avoidance of sunlight was recommended and treatment
with nicotinamide commenced. She developed bowing
of her legs, which did not improve with cholecalciferol
supplementation. At this point, her paediatrician sus-
pected a diagnosis of RFS, rather than Hartnup disorder,
commenced treatment with 1,25-OH cholecalciferol and
referred her for further investigations. There was no
family history of renal disease.
On examination, she had genu varum and hepatomegaly,
but no other dysmorphic findings. Her height was well
below and weight on the 3rd percentile. Laboratory investi-
gations revealed a metabolic acidosis, hypophosphataemia
and markedly raised alkaline phosphatase (ALP: 2323 IU/l,
normal for age < 280) with generalized aminoaciduria,
glycosuria and tubular proteinuria, consistent with RFS.
Leukocyte cystine content was normal and slit lamp exam-
ination did not show corneal cystine crystals, excluding a
diagnosis of cystinosis, the most common cause of RFS in
childhood. Radiological examination showed healing rick-
ets with normal appearance of liver and kidneys on ultra-
sound. A diagnosis of autosomal recessive RFS was made
and she received treatment with 1-OH cholecalciferol,
phosphate, calcium and bicarbonate supplementation with
clinical improvement of her rickets and good catch-up
growth. Fasting glucose levels were repeatedly low. She
was admitted again age 4 years for further investigations. A
liver biopsy was normal, with no evidence for a glycogen
storage disorder, tyrosinaemia or Wilson disease. A fruc-
tose–free diet had no effect, excluding fructose intolerance.
Over the following years she was admitted multiple times
for investigations, including 2 kidney biopsies (age 4 and
16 years), a bone marrow aspirate and serial measurements
of glomerular filtration rate (GFR). Despite only moder-
ately decreased GFR (47 ml/min/1.73m2), a DMSA scan of
the kidneys age 5 years showed essentially no accumulation
of tracer in the kidneys (Fig. 1a). A mild degree of nephro-
calcinosis was noted first age 9 years, which remained
stable thereafter.
She was transferred to adult services age 17 years with
ongoing supplementation with 1-OH cholecalciferol, cal-
cium, phosphate and bicarbonate. Another kidney biopsy
was performed age 25 years, which now showed abnor-
mal mitochondria (Fig. 1b). She reported episodes of
fainting, especially if fasting for prolonged periods of
time and consequently maintained a strictly regular
dietary intake.
The patient had a first child age 34 years with normal
pregnancy and postnatal examinations. She was coun-
seled that due to the presumed autosomal recessive in-
heritance of her disorder, recurrence of the disease in
her children would be unlikely.
Her second child was born at 30-weeks gestation with
a weight of 1.53 kg after an uncomplicated pregnancy.
Fig. 1 DMSA and biopsy of the kidneys. a DMSA scan showing tracer mostly in the bladder with no apparent uptake in the kidney, reflecting
impaired proximal tubular transport of tracer in renal Fanconi syndrome. b Electron microscopy picture (magnification 19,500×) of a proximal
tubular epithelial cell. Note the abnormal morphology of mitochondria, consistent with a mitochondrial cytopathy
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He was noted to have recurrent hypoglycaemia in the
neonatal period and transferred to GOSH. Investigations
revealed hyperinsulinism, as well as highly raised ALP
(2730 IU/l), glycosuria, tubular proteinuria, hypercalci-
uria and renal phosphate wasting, consistent with RFS.
A screen of genes involved in hyperinsulinism revealed a
heterozygous mutation c.187C > T; p.Arg63Trp in
HNF4A, encoding Hepatocyte Nuclear factor 4A. The
mutation was subsequently also confirmed in the mother.
At last follow-up in December 2015 she remained clinic-
ally stable with ongoing biochemical features of RFS. Con-
tinuous glucose monitoring revealed prolonged overnight
hypoglycaemia and post-prandial hyperglycaemia.
Discussion and Conclusions
Our case highlights the dramatic recent improvements
in our understanding of rare inherited disorders. The
patient underwent multiple admissions and invasive in-
vestigations over a period of more than 20 years, yet
without ever having a definitive diagnosis established,
except for the initial misdiagnosis of Hartnup disorder.
In contrast, her son was diagnosed within the first
months of life, as part of our protocol for assessing per-
sistent hypoglycaemia, which includes comprehensive gen-
etic testing for genes involved in hyperinsulinism [5, 6].
Establishing the specific diagnosis is relevant, as it al-
lows accurate genetic counseling, early identification of
future children and optimized management of the hy-
perinsulinism with diazoxide to prevent episodes of
hypoglycaemia.
Mutations in HNF4A were initially identified as a
cause of diabetes (MODY type 1), but can also cause hy-
perinsulinism early in life [7]. The disorder is inherited
in an autosomal dominant fashion. Notably, the addi-
tional finding of RFS is only associated with the specific
mutation Arg63Trp (previously annotated as Arg76Trp)
[8]. The cause for the renal involvement with this spe-
cific mutation is unclear, but the abnormal mitochondria
on biopsy in our patient suggest an important role for
HNF4A in maintaining mitochondrial integrity in the
kidney. Not surprisingly, given the high energy demand
of the proximal tubule, mitochondrial dysfunction is one
of the best recognised causes of RFS [3]. Indeed, investi-
gations in drosophila suggest an important role for
HNF4 in the regulation of mitochondrial genes [9].
The recurrent hypoglycemia in our patient was noted,
but erroneously attributed to the glycosuria by the inves-
tigating metabolic doctors at the time. It is important to
note that loss of sugar in the urine, even with severe forms
of familial renal gycosuria, where glucose loss can exceed
150 g per day, is not associated with hypoglycemia,
presumably due to the tight regulation of blood glucose
levels [10].
An interesting additional finding in our patient was
the absence of renal DMSA accumulation. This is con-
sistent with a previous report in RFS and likely reflects
defective proximal tubular uptake of the tracer [11]. It is
debated whether renal extraction of DMSA occurs via
initial filtration and subsequent apical uptake or through
basolateral uptake. The finding of absent renal extraction
of DMSA, yet presence in the bladder clearly argues for
apical uptake since impaired basolateral transport would
prevent DMSA from appearing in the urine. Impaired
luminal uptake is also consistent with experiments in
megalin/cubilin deficient mice, which showed depend-
ence of renal extraction on intact receptor-mediated
endocytosis in the proximal tubule [12].
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